Cogent Biosciences Inc COGT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/24/21 EDT
8.61UNCH (UNCH)
Volume
6,593
Close
8.61quote price arrow up+0.07 (+0.82%)
Volume
27,528
52 week range
5.83 - 14.44
Loading...
  • Open8.51
  • Day High8.68
  • Day Low8.51
  • Prev Close8.54
  • 52 Week High14.44
  • 52 Week High Date10/27/20
  • 52 Week Low5.83
  • 52 Week Low Date08/03/21

Key Stats

  • Market Cap343.11M
  • Shares Out39.85M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta3.07
  • YTD % Change-23.33

KEY STATS

  • Open8.51
  • Day High8.68
  • Day Low8.51
  • Prev Close8.54
  • 52 Week High14.44
  • 52 Week High Date10/27/20
  • 52 Week Low5.83
  • 52 Week Low Date08/03/21
  • Market Cap343.11M
  • Shares Out39.85M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta3.07
  • YTD % Change-23.33

RATIOS/PROFITABILITY

  • EPS (TTM)-11.89
  • P/E (TTM)-0.72
  • Fwd P/E (NTM)-5.75
  • EBITDA (MRQ)-96.177M
  • ROE (MRQ)-264.58%
  • Revenue (MRQ)310,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-28,717.31%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cogent Biosciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. The Company's most advanced program is CGT9486, a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation, as well as other mutations in KIT exon 17, to treat Systemic Mastocytosis (SM) and gastrointestinal stromal tumors (GIST). GT9486 has demonstrated clinical activity and safety results in a Phase I/II clinical...
Peter Harwin
Non-Executive Chairman
Andrew Robbins
President
John Green
Chief Financial Officer
Address
200 CAMBRIDGE PARK DRIVE, SUITE 3100
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
AMPE
Ampio Pharmaceuticals Inc
1.78-0.01-0.56%
NLTX
Neoleukin Therapeutics Inc
7.27-0.41-5.34%
BDTX
Black Diamond Therapeutics Inc
9.29-0.34-3.53%
APLT
Applied Therapeutics Inc
15.68-1.05-6.28%
OYST
Oyster Point Pharma Inc
12.30-0.04-0.32%